Our research group has reported much research about SADBE-induced ACD; we will further validate whether RANKL protects humans from ACD, or ACD downregulates IL9 and upregulates the expression of GROα, TRAIL, C4, and Complement factor B. This evidence concerns the gene TNFSF10 and granular corneal dystrophy type II.